Published in Br Heart J on July 01, 1978
Cardiac sequelae of acute head injury. Br Heart J (1982) 1.06
Chick embryo partial ischemia model: a new approach to study ischemia ex vivo. PLoS One (2010) 0.75
1,2-Dichloroethane-induced toxic leukoencephalopathy with a brain biopsy. Neurol Sci (2014) 0.75
The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. Circulation (1973) 1.78
Combined isoenzyme analysis in the diagnosis of myocardial injury: application of electrophoretic methods for the detection and quantitation of the creatine phosphokinase MB isoenzyme. J Lab Clin Med (1972) 1.19
Specificity of serum creatine kinase isoenzymes in diagnosis of acute myocardial infarction. Br Med J (1973) 1.12
Brain creatine kinase in blood after acute brain injury. J Neurol Neurosurg Psychiatry (1975) 1.10
Origin of elevated serum enzyme activities after direct-current countershock. N Engl J Med (1969) 1.06
Demonstration of serum creatine kinase isoenzymes by fluorescence technique. Clin Chim Acta (1972) 1.02
Cardiac abnormalities in subarachnoid hemorrhage: a resumé. Stroke (1974) 1.00
Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations. Am J Cardiol (1976) 0.99
Elevated plasma MB creatine phosphokinase activity. A specific marker for myocardial infarction in perioperative patients. Arch Intern Med (1976) 0.98
Myocardial damage and cardiac arrhythmias after intracranial hemorrhage. A critical review. Stroke (1975) 0.97
Brain-type creatine kinase isoenzyme. Occurrence in serum in acute cerebral disorders. Arch Neurol (1977) 0.94
Creatine kinase MB isoenzyme studies in diagnosis of myocardial infarction. Br Heart J (1976) 0.92
Creatine kinase isoenzymes in neuromuscular diseases. J Neurol Sci (1976) 0.87
Serum enzymes and isozymes. Extrapulmonary sources in acute pulmonary embolism. Arch Intern Med (1974) 0.80
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology (2012) 2.86
Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology (2011) 2.22
The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg (1989) 2.20
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke. Eur J Neurol (2007) 2.10
Muscle-eye-brain disease (MEB) Brain Dev (1989) 2.00
Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) (1988) 1.90
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75
Celiac disease, brain atrophy, and dementia. Neurology (1991) 1.69
Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 1.69
Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol (2001) 1.59
Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg (1997) 1.57
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56
Diagnostic value of cerebrospinal fluid adenosine deaminase determination. Scand J Infect Dis (1991) 1.52
Neuropsychological sequelae of cardiac arrest. JAMA (1993) 1.52
Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology (2003) 1.47
Ocular findings in muscle-eye-brain (MEB) disease: a follow-up study. Brain Dev (1995) 1.44
Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke (1993) 1.42
Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge. Nutr Metab Cardiovasc Dis (2010) 1.39
Progressive unilateral hypertrophic myopathy: a case study. Muscle Nerve (1993) 1.39
Ethanol intoxication: a risk factor for ischemic brain infarction in adolescents and young adults. Stroke (1982) 1.37
An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet (1995) 1.36
Clinical determinants of poststroke dementia. Stroke (1998) 1.36
Depression after stroke: results of the FINNSTROKE Study. Stroke (1998) 1.32
Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation (1996) 1.30
Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest (1992) 1.30
Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia (1999) 1.29
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis (1998) 1.29
Snoring as a risk factor for sleep-related brain infarction. Stroke (1989) 1.29
Gene deletions in X-linked muscular dystrophy. Am J Hum Genet (1989) 1.29
Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology (2001) 1.28
Diagnosis and management of brain death. Br Med J (1979) 1.28
Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke (2001) 1.27
Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun (1990) 1.25
White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24
Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology (1997) 1.23
Thromboembolism in patients with atrial fibrillation. Arch Neurol (1984) 1.22
Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21
Frequency and clinical determinants of poststroke depression. Stroke (1998) 1.20
Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A (2000) 1.18
Assignment of the tibial muscular dystrophy locus to chromosome 2q31. Am J Hum Genet (1998) 1.17
Is chronic brain damage in boxing a hazard of the past? Lancet (1982) 1.17
Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2006) 1.16
Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol (1990) 1.16
Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med (1989) 1.15
Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol (1998) 1.13
Specificity of serum creatine kinase isoenzymes in diagnosis of acute myocardial infarction. Br Med J (1973) 1.12
Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke (1995) 1.12
Muscle-eye-brain disease: a neuropathological study. Ann Neurol (1997) 1.12
Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol (1996) 1.11
Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke (1996) 1.11
Brain creatine kinase in blood after acute brain injury. J Neurol Neurosurg Psychiatry (1975) 1.10
Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol (2002) 1.10
Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol (1989) 1.10
Determination of serum creatine kinase isoenzymes in myocardial infarction. Am J Cardiol (1972) 1.09
How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09
Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology (2006) 1.07
Origin of elevated serum enzyme activities after direct-current countershock. N Engl J Med (1969) 1.06
Insomnia in ischemic stroke patients. Cerebrovasc Dis (2002) 1.06
Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol (2003) 1.05
Outcome of 314 patients with transient ischemic attacks. Stroke (1982) 1.05
Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test. Eur J Clin Pharmacol (1981) 1.05
Oral contraceptives after liver disease. Br Med J (1971) 1.05
Demonstration of serum creatine kinase isoenzymes by fluorescence technique. Clin Chim Acta (1972) 1.02
Muscular dystrophy with separate clinical phenotypes in a large family. Muscle Nerve (1991) 1.02
Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke (1999) 1.01
Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running. Scand J Med Sci Sports (2001) 1.01
Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation. Br Heart J (1970) 0.99
Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry (1999) 0.99
Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry (2001) 0.99
Low prevalence of Huntington's disease in Finland. Lancet (1987) 0.99
The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke (2000) 0.99
Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations. Neuromuscul Disord (2001) 0.98
Subarachnoid haemorrhage: long-term follow-up results of late surgical versus conservative treatment. Br Med J (1978) 0.98
Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion. Clin Pharmacol Ther (1974) 0.97
Effects of ethanol on platelet function. Alcohol (1985) 0.97
MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol (2003) 0.97
Neuronal intranuclear inclusion disease in identical twins. Ann Neurol (1984) 0.96
Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol (1999) 0.96
Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke (1997) 0.96
Muscle-eye-brain disease and Walker-Warburg syndrome. Am J Med Genet (1990) 0.95
Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients. Neurology (2011) 0.95
Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand (1998) 0.95
Microangiopathy with encephalopathy, hearing loss and retinal arteriolar occlusions: two new cases. J Neurol Sci (1988) 0.95
Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke (1980) 0.95
Brain-type creatine kinase isoenzyme. Occurrence in serum in acute cerebral disorders. Arch Neurol (1977) 0.94